Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA grants Breakthrough Therapy Designation status for acalabrutinib

europeanpharmaceuticalreviewAugust 02, 2017

Tag: acalabrutinib , FDA

PharmaSources Customer Service